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Voltage-gated sodium channels (VGSCs) are transmembrane proteins which function
as gates that control the flux of ions across the cell membrane. They are key ion
channels for action potentials in excitable tissues and have important physiological
functions. Abnormal function of VGSCs will lead to dysfunction of the body and trigger
a variety of diseases. Various studies have demonstrated the participation of VGSCs
in the progression of different tumors, such as prostate cancer, cervical cancer, breast
cancer, and others, linking VGSC to the invasive capacity of tumor cells. However, it
is still unclear whether the VGSC regulate the malignant biological behavior of tumors.
Therefore, this paper systematically addresses the latest research progress on VGSCs
subunits and tumors and the underlying mechanisms, and it summarizes the potential of
VGSCs subunits to serve as potential targets for tumor diagnosis and treatment.
Keywords: VGSCs, tumors, metastasis, expression regulation, mechanism
INTRODUCTION
In general, ion channels including VGSC, are hydrophilic protein microchannels traversing
the semi-permeable cell membranes regulating intracellular ion concentrations, facilitating
signaling pathways, and influencing cell behavior. VGSC play a key role in generating
electrochemical action potentials in excitable cells, participate in maintaining homeostasis and are
an important components of physiological activities such as muscle contraction, cell proliferation
(1) and cognitive activities. Interestingly, VGSCs are also expressed in “non-excitable” cells
such as fibroblasts, various immune cells of the myeloid linage (2), and glial cells such as
astrocytes, microglia, and oligodendrocyte precursor cells (3). An exciting example is the
expression of the VGSC NaV1.5 in late endosomes of macrophages (4). After activation
with LPS this sodium channel regulates phagocytosis and endosomal pH causing acidification
via sodium eﬄux. Furthermore, these molecules are also present in cancer cells from e.g.,
colon, breast, prostate, and non-small cell lung cancer. In these transformed cells they are
involved in tumor growth, invasion, and metastasis (5–9). This contribution of VGSC to
cancer malignancy and to the resistance of tumors to chemotherapy drugs has become
the focus of research. Nevertheless, the specific underlying mechanisms of Na+ channels
affecting these changes in cancer cells are still unclear and need to be explored further.
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STRUCTURE AND FUNCTION OF VGSCs
VGSC is a multi-subunit, transmembrane glycoprotein that
is activated by voltage changes in the cell membrane. It’s
usually composed of a α subunit (220–260 kD) and one or
more β subunits (33–36 kD) (Figure 1) (10). The nine α
subunits are termed Nav1.1–Nav1.9 which are encoded by nine
different genes (SCN1A-SCN11A). Tetrodotoxin is a specific
blocker of sodium channels and according to their varying
sensitivity to tetrodotoxin VGSCs are divided into tetrodotoxin-
sensitive (TTX-S) and tetrodotoxin-resistance (TTX-R) forms
(11). Nanomolar concentrations of TTX can block TTX-
sensitive VGSC function, whereas resistant forms are blocked
by micromolar concentrations of TTX. TTX-resistant molecules
include Nav1.5, Nav1.8, and Nav1.9. All other α subunits are
TTX-S (12). The α subunit comprises the functional centers of
VGSC and consists of 4 highly similar transmembrane domains
(I-IV) (Figure 1). Each domain contains 6 transmembrane
segments of an α-helix (S1–S6). S4 is a voltage sensor which,
after stimulation, moves the S4 transmembrane segment out of
the membrane, causing the three-dimensional structure of the
channel protein to change, thereby achieving channel opening
(13). The S5 and S6 sections enclose the central pore domain and
their insertion sequences constitute the selectivity filter, which
determines Na+ selectivity and functions as a gate (14). There
are multiple protein kinase phosphorylation sites between the
I and II domains. The short chains of the III and IV domains
in the cytoplasmic region, which can close open channels from
inside of the cell during rapid depolarization, causing channel
inactivation. This area could be an important target for drugs
(10). In addition, studies also have found that there are three
hydrophobic amino acids (1488-IFM−1490) in the middle of the
polypeptide linkage site between S6 in the III domain and S1 in
the IV domain that can inactive channels (15). The traditional
idea is that a single α-subunit acts as a monomer, but it has been
proposed in the literature that the sodium channel α subunit
not only physically interact with each other, but they actually
combine, and act as dimers (16).
The β subunit is an auxiliary subunit of the Na+ channel and
has five subtypes: β1, β1B, β2, β3, and β4, which are encoded
by the genes SCN1B-SCN4B. With the exception of β1B, the β
subunit consists of an α-helical transmembrane domain linking
the extracellular N-terminus and the intracellular C-terminus.
The β1B subunit variant lacks a transmembrane protein domain
with a secretory function. The β1 and β3 subunits have high
homology, bind to the α subunit in a non-covalent manner, and
the β2 and β4 subunits have high homology, and are bound by
a covalent disulfide bond. The β subunit does not participate in
the formation of the pore structure of the channel, but changes
the gating, voltage dependence, and kinetics of the VGSC alpha
subunit, thereby regulating the excitability of cells in vivo (17).
In addition, a recent study has found that β subunits can affect
the function of the α subunit and regulate its biophysical and
pharmacological properties along with channel phosphorylation
(18). Furthermore, the β subunit regulates the expression of
voltage-gated ion channels on the plasma membrane and acts as
a cell adhesion molecule that interacts with cytoskeletal proteins,
extracellular matrix, and other cell adhesion molecules affecting
cell adhesion and migration activities (19, 20).
The α subunit contains four transmembrane domains (I–IV),
each domain contains 6 transmembrane helices (S1–S6), and
S4 is a voltage sensor. Phosphorylation sites of multiple protein
kinases between the I and II domains, intracellular short peptides
between the III and IV domains can inactivate the channel.
The β subunits contain an extracellular immunoglobulin loop,
intracellular C-terminal domain, and a transmembrane domain.
It is of interest that the expression of VGSC in glial cells
such as astrocytes results in fully functional channels that can
support a significant action potential (21). This suggests an as
of yet unresolved role of this class of molecules in astrocytes. In
microglia it has been shown that sodium channels are regulating,
for example, cell behavior such as lamellipodia formation and
motility (22) and specifically the production and release of the
proinflammatory cytokines IL-1α, IL1β, and TNF-α (23).
VGSCs and Tumors
Previous analyses of various tumor tissues have found that their
intrinsic concentration of sodium ions is significantly higher than
that of surrounding normal tissues and is closely related to the
formation of tumors (24). Furthermore, it could be shown that a
high expression of VGSC in various tumors is closely related to
malignant biological behavior.
Prostate Cancer
Using the patch clamp technique to analyse sodium currents
in rat prostate cancer cells an inward sodium current could
be detected in highly metastatic Mat-Ly-Lu but not in weakly
metastatic AT-2 prostate cancer cells. This flow of sodium ions
could be blocked by 600 nM tetrodotoxin. Moreover, results from
the study showed that the use of TTX significantly reduced the
invasive ability of Mat-Ly-Lu cells while it had no significant
effect on AT-2 cells (25). Furthermore, a comprehensive
quantitative expression study of all subtypes of the VGSC α
subunit was carried out in normal prostate, benign prostatic
hyperplasia (BPH) and prostate cancer cells. It found that in PC-
3 and LNCaP cells, two typical prostate cancer cell lines, Nav1.6
and Nav1.7 were highly expressed with their mRNA levels 6–
27 times higher in PC-3 and LNCaP than in normal or BPH
samples. However, while the expression of Nav1.6 and Nav1.7 is
highly functional in highly metastatic PC-3 cells it has no effect
in LNCaP cells as shown by using patch clamp technique to
record whole cell currents (26). In the Copenhagen rat model
of prostate cancer the number of lung metastases is reduced by
>40% after blocking VGSC activity in primary tumors using
tetrodotoxin. This extends the lifespan of the experimental
animals greatly suggesting that VGSC activity promotes prostate
cancer metastasis in vivo (27). Furthermore, a recent study found
that Naringenin, a natural compound found in citrus fruits and
tomatoes, reduced the invasion and proliferation of prostate
cancer MAT-LyLu cells by inhibiting the activity of VGSCs
encoded by the SCN9A gene (28).
Frontiers in Oncology | www.frontiersin.org 2 March 2019 | Volume 9 | Article 124
Mao et al. Voltage-Gated Sodium Channels and Tumors
FIGURE 1 | The structure of voltage-gated sodium channel.
Breast Cancer
Breast cancer is the most common malignant cancer among
women. Its mortality is extremely high and death occurs
mostly after metastasis. Roger et al. reported for the first time
that a unique, rapid inward sodium current was found in
highly invasive breast cancer MDA-MB-231 cells, whereas no
introversion current was found in weakly invasive MCF-7 and
MDA-MB-468 cells. In addition, currents in MDA-MB-231 cells
were blocked by high concentrations of tetrodotoxin (TTX).
This reduced invasiveness by ∼30% (29). Similarly, Gillet et al.
demonstrated that TTX blocked continuous sodium influx in
MDA-MB-231 breast cancer cells, and knockdown of NaV1.5
expression reduced cell invasiveness, while using sodium channel
activator veratridine had the opposite effects (30). In a separate
investigation it could be shown that the activity of Na+ channels
increased cell motility and endocytosis. As a consequence, this
caused an increased invasiveness of metastatic human breast
cancer cells. In addition, the expression of a “neonatal” splicing
form of VGSC in these cells was increased and directly related
to metastatic potential (31). Recent studies have found that the
protein levels of Nav1.5 are upregulated in metastatic breast
cancer cells compared to normal breast tissue. Moreover, down-
regulation of Nav1.5 significantly decreased tumor growth,
invasion, and spread of metastases to liver, lung, and spleen (8).
Phenytoin, an antiepileptic drug, has been found to inhibit
the transient and sustained Na(+) flow recorded in strongly
metastasizing MDA-MB-231 breast cancer cells (32). It inhibited
the migration and invasion of MDA-MB-231 cells significantly at
concentrations within the therapeutic range for treating epilepsy,
but had no effect on weakly metastatic MCF-7 cells that did
not display Na+ currents. Thus, phenytoin may be a potential
therapeutic drug to treat patients with metastatic breast cancer.
In addition, the clinically used drug Ranolazine could inhibit
Nav1.5 current in breast cancer cells and reduce the invasiveness
of cancer cells in vitro. In in vivo experiments, mice injected
with Ranolazine significantly reduced lung colonization by breast
cancer cells expressing Nav1.5 (33). Furthermore, a recent study
designed and synthesized 5 small compounds as inhibitors
of Nav1.5-associated inward currents in MDA-MB-231 breast
cancer cells. The most active compound blocked the sodium flow
by 34.9± 6.6% at 1µMand inhibitedMDA-MB-231 cell invasion
without affecting cell viability (34).
Cervical Cancer
The whole-cell patch clamp technique was employed to isolate
and identify voltage-gated Na+ currents as a major component
of the inward flow in cervical cancer cells (35). While in normal
cervical biopsies exclusively the expression Nav1.4 transcripts
was detectable by RT-PCR in primary cultures obtained from
human cervical cancer biopsies, the mRNAs of the additional
subunits Nav1.2, Nav1.6, and Nav1.7 could be detected. This
study showed for the first time the functional and distinct
expression of specific VGSCs human cervical cancer cells,
suggesting that the VGSCs potentially could be used as a
marker for diagnosis or treatment prognosis of human cervical
cancer. Another study showed that the mRNA level of Nav1.6
α subunit in cervical cancer samples was ∼40-fold higher
than in non-cancerous cervical biopsies (6). Using cell patch
clamp experiments, the Nav1.6-specific toxin Cn2 (Centruroides
noxius Beta-mammal toxin) blocked ∼30% of the total sodium
current confirming the functional activity of Nav1.6 channels
in the plasma membrane of cervical cancer cells. In vitro
assays, the blocking of VGSC by tetrodotoxin and Cn2 did
not affect cell proliferation and migration, but reduced the
invasiveness of primary cervical cancer cells by about 20%.
This study suggests that the up-regulated expression of Nav1.6
in cervical cancer could be useful as a new marker for the
metastatic behavior of this tumor. Additionally, Na1.6 expression
is significantly up-regulated during transformation of cervical
epithelium increasing MMP-2 activity and causing metastatic
invasiveness of cervical cancer cells (36).
Colon Cancer
Using RT-PCR and immunohistochemistry the expression of
Nav1.5 has been detected in HT29, SW620, and SW480 colon
cancer cells. Furthermore, strong Nav1.5 protein staining was
found in colon cancer specimens while little to no staining was
detected in matching normal colon tissues. Importantly, the
Frontiers in Oncology | www.frontiersin.org 3 March 2019 | Volume 9 | Article 124
Mao et al. Voltage-Gated Sodium Channels and Tumors
invasive potential of colon cancer cells was inhibited by Nav1.5-
specific small interfering RNAs, indicating that the Nav1.5-
encoding gene SCN5A may be involved in the regulation of
cell invasion-related signaling pathways (7). Recently, the same
group could associate channel activity with Rap1-dependent
sustained MAPK activation in the human colon cancer cell
line SW620 by using pharmacological inhibitors/activators
and siRNA interference. And they further demonstrated that
activation of sodium channel-induced expression changes
of invasion-related genes through the PKA/ERK/c-JUN/ELK-
1/ETS-1 transcriptional pathway (37).
Lung Cancer
Lung cancer is histopathologically divided into two major
categories: non-small cell lung cancer and small cell lung
cancer which are accounting for 80 and 20% of lung cancer,
respectively. In the human small-cell lung cancer (SCLC) cell
line H510, Nav1.3, 1.5, 1.6, 1.9 are expressed and may enhance
the capacity of tumor cells for endocytosis suggesting that a
high expression of VGSC could be responsible for the increased
capacity of tumor cells to metastasize (38). In human non-small
cell lung cancer, voltage-dependent sodium currents are present
in strongly metastatic H23 and H460 cells, whereas no VGSC
current has been found in normal NL20 cells or in low metastatic
A549 cells. The VGSC blocker TTX reduces the invasive capacity
of H23, H460 cells by 40–50% while it has no effect in A549, NL-
20, and BEAS-2B cells (39). Together, these results suggest that
functional expression of VGSC might be an integral component
of the metastatic process in lung cancer cells.
Ovarian Cancer
The relative mRNA expression levels of Nav1.1, Nav1.3, Nav1.4,
and Nav1.5 in ovarian cancer cells are significantly higher than
those in normal ovarian tissues (5). Furthermore, the mRNA
expression levels of Nav1.2, Nav1.4, Nav1.5, and Nav1.7 are
greatly increased in the strongly metastatic ovarian cancer cell
lines, Caov-3 and SKOV-3, compared to the weakly metastatic
Anglne cells. In addition, treatment of Caov-3 and SKOV-3 cells
with TTX reduces their migration and invasion by 50–60% with
no effect on proliferation. Immunohistochemical staining and
Western blot results show that the Nav1.5 protein is significantly
elevated in ovarian cancer tissue and cell lines compared
to normal ovarian tissues suggesting that SCN5A/Nav1.5 is
important for occurrence and development of ovarian cancer.
The Mechanism of VGSC Regulating
Cancer Metastasis
Numerous studies have demonstrated that VGSC plays an
important role in tumor metastasis. However, the mechanism
by which VGSC promotes the metastasis of cancer cells
is not yet fully understood. Currently, there are some
hypotheses (Figure 2).
Firstly, sodium influx could be involved in tumor progression.
The high expression of VGSC in tumors causes strong
Na+ influxes. The Sodium–hydrogen antiporter 1 (NHE1),
a hydrogen ion channel is co-expressed with VGSC to
regulate H+ eﬄux. This leads to intracellular alkalization
and extracellular acidification. An extracellular acidic pH
facilitates the activation of cysteine cathepsins B and S
that degrade the extracellular matrix, thereby enhancing
pH-dependent tumor cell invasion and metastasis (30, 40,
41). Furthermore, study in MDA-MB-231 breast cancer cells
indicating that Nav1.5 expression increases Src kinase activity
and the phosphorylation of the actin-nucleation promoting
factor cortactin. This results in cytoskeletal changes such as
the formation of invadopodia. Subsequently, the cells acquire
an elongated, invasive morphology which increases the ability
of cells to metastasize (42). Furthermore, Na+ influx activates
voltage-gated calcium channels, which increase intracellular
Ca2+ concentration. After VGSC activation, mitochondria
rapidly uptake Na+ and then release Ca2+ into the cytosol (32).
This process enhances the formation of podosomes/invadopodia
and promotes tumor cell invasion (43). However, it is unclear
how VGSCs which are present in the vesicle membrane interact
with VGSCs present in the plasma membrane. A mechanism
that eludes to a role of VGSC in non-excitable tumor cells has
been proposed in an analysis of these channels in astrocytes. In
these glia cells the presence of VGSC could provide a pathway
for sodium ions to return to the cytoplasm and thus to maintain
the activity of the Na+/K(+)-ATPase (44). This mechanism is
proposed to contribute to the ion homeostasis in the extracellular
space in the brain and could also be important in tumors.
Secondly, the behavior of VGSCs that alters tumor cells to
a metastatic phenotype is related to the β subunit. It has been
reported that in breast cancer cells, β1 mRNA and protein levels
are significantly higher in the weak metastatic MCF-7 cell line
than in the high metastatic MDA-MB-231 cell line. Inhibition of
β1 expression in MCF-7 cells by siRNA increased cell motility
by reducing cell adhesion (45). In addition, overexpression of
β2 in prostate cancer LNCaP cells increases cell migration and
invasion (46). Therefore, β1 and β2 may play different functional
roles in different cells, and the tumor in vivo may be different
compared with cultured cells. However, since the β subunits are
Ig family cell adhesion molecules, it can be speculated that their
regulation of cancer cell metastatic behavior may be through
regulation of adhesion/separation. Moreover, fyn kinase is a
critical signaling intermediary in the mechanism during β1-
mediated process outgrowth in tumor cells (47). Recently, in the
study of breast cancer, it was first demonstrated that SCN4B /β4
protein is expressed in non-cancer epithelial cells, but expression
was reduced in cancer tissues, and was almost absent in high-
grade tumors and metastases. In cancer cells, by promoting
the amoeboid-mesenchymal hybrid phenotype, reducing β4
expression increases RhoA activity and enhances cell migration
and invasiveness. In contrast, overexpression of SCN4B/β4
reduced the aggressiveness of cancer cells, tumor growth, and
metastasis progression (48). Similarly, a retrospective study of the
database revealed that mRNA and protein levels of SCN4B were
significantly down-regulated in papillary thyroid cancer (PTC)
compared to normal thyroid tissue, and its expression may be
inhibited by DNA hypermethylation (49). These findings indicate
that SCN4B/β4 may be a suppressor gene of cancer metastasis.
Moreover, VGSC can regulate gene expression. Currently, a
novel gene interaction network related to cancer invasion has
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FIGURE 2 | The mechanism of VGSC-induced cancer metastasis.
been simulated in HT29 colon cancer cell line and SCN5A is a key
regulator of the gene networks involved in metastatic invasion
(7). This suggests that Nav1.5 may be an early entry point to the
signaling mechanism.
The sodium ion influx activates the Sodium–hydrogen
antiporter NHE1, which leads to a low intracellular pH,
enhances the hydrolysis activity of cathepsins, and degrades
the extracellular matrix. In addition, after VGSC activation,
mitochondria rapidly absorb Na+ and release Ca2+, and then
activate a cell-signaling cascade to promote the formation of
invasive podosomes. These processes enhance the cell invasion
ability. The β subunit changes the cell morphology and affects the
movement of cells through adhesionmechanisms that require fyn
kinase and Na+ current.
Molecular Mechanisms of VGSC
Regulation
Various molecular mechanisms regulate VGSC expression and
function including the presence of growth factors and the effects
of hormones. Additionally, the VGSC expression has been shown
to have a negative feedback effect on its own expression.
Growth Factors
Growth factors play an important role in the occurrence and
development of tumors. Their receptors and corresponding
signaling pathways are considered to be putative targets of
tumor therapy (50, 51). In prostate and non-small cell lung
cancer cells, epidermal growth factor (EGF) can upregulate the
expression of Nav1.7 and promote the migration of cancer cells
(52, 53) or promote cell invasion through the ERK1 /2 pathway,
respectively (54). The study of non-small cell lung cancer shows
that the ability of EGF to promote cell invasion deceases after
silencing Nav1.7 expression, suggesting that EGF can enhance
cell invasion by regulating VGSC (48). Furthermore, vascular
endothelial growth factor (VEGF) can promote angiogenesis that
plays an important role in the process of tumor cell invasion
(55). Currently, in the DRG neurons of the bladder, VEGF
has been found to increase cellular excitability by up-regulating
VGSC expression (56). In addition, stimulation ofmouse prostate
cancer cells with nerve growth factor (NGF) upregulates the
expression of Nav1.7, and in human prostate cancer cells, the
promoter region of SCN9A (encoding Nav1.7) can be activated
by NGF (57, 58).
Hormones
A study found that in cardiomyocytes, Foxo1 directly binds
the insulin response elements in the SCN5A promoter region
and negatively regulates Nav1.5 expression (59). In adrenal
cells, insulin upregulated the expression of Nav1.7, which was
mediated by PI3K-induced GSK-3β inhibition (60). In addition,
in MDA-MB-231 breast cancer cells, insulin can upregulate
VGSC expression in the plasma membrane and enhance the
ability of cell migration (61). In human BCa cells, strongly
metastatic MDA-MB-231 cells express functional VGSC but lack
ER. Conversely, weakly metastatic MCF-7 cells are ER positive
and do not express any functional VGSC (31). Similarly, there
is a negative association between basal expression of androgen
receptor (AR) and VGSC in PCa cells, i.e., weakly/non-metastatic
cells do not possess functional VGSCs (62). However, the latest
studies in patients with non-metastatic colon cancer show that
high expression of Nav1.5 is associated with high ER-β expression
and has been identified as a predictor of low 5-year DFS rates in
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patients (63). In conclusion, the expression of VGSC is closely
associated with the secretion of hormones.
Self-Regulation
In excitable cells, the expression of VGSCs is often regulated
by negative feedback. Chronic treatment with VGSC openers
leads to a reduction of mRNA/protein expression, conversely,
treatment with VGSC blockers increases functional protein
expression (64–66). However, there is positive feedback in the
expression of Nav1.7 in strongly metastatic PCa MAT-LyLu cells.
After TTX inhibition of VGSC, phosphorylation of PKA was
reduced. At the same time, after the use of PKA inhibitors,
voltage-gated sodium ion current decreased, while agonists
added with PKA increased voltage-gated sodium currents (67,
68). A similar positive feedback mechanism can be found in
MDA-MB-231 breast cancer cells (69).
CONCLUDING REMARKS
Malignant tumors constitute a serious threat to human
health. With the deepening of interdisciplinary research
in molecular biology, cell biology, and pharmacology, the
research on the relationship between ion channels and
tumors has made great progress. It has been elucidated
that VGSCs can be expressed in invasive cancer cells and
can increase the ability of tumor cells to move and invade.
Therefore, they can be considered to be important regulators
of cancer development. However, the expression of the α
and β subunits of VGSCs in different tumors and their
role in disease progression need to be further investigated.
In addition, the molecular mechanisms involved in the
regulation of VGSCs activity are still unclear. Some of the
channel blockers currently being developed may act as an
intervention for metastatic disease. This will facilitate the use
of VGSCs as a diagnostic marker for early diagnosis and as
a therapeutic target in the treatment of clinical metastatic
tumor diseases.
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